智通财经APP获悉,Esperion Therapeutics(ESPR.US)披露日本第一三共欧洲子公司Daiichi Sankyo Europe(DSE)不同意其拖欠该公司的两种含bempedoic acid的降胆固醇药物的里程碑付款。截至发稿,Esperion盘后跌近54%,报1.72美元 Espierion... 网页链接
$Esperion(ESPR)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-015820 Act: 34 Size: 20 MB 网页链接
$Esperion(ESPR)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-015824 Act: 34 Size: 2 MB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011485 Size: 6 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011488 Size: 20 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011492 Size: 22 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011490 Size: 21 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011494 Size: 20 KB 网页链接
$Esperion(ESPR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-007066 Act: 34 Size: 9 MB 网页链接
$Esperion(ESPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-007035 Act: 34 Size: 253 KB 网页链接
$Esperion(ESPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023419 Act: 34 Size: 61 KB 网页链接